Clinical Trial Update: Clinical Trial of Tolcapone for Cognition in Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of tolcapone for cognition in schizophrenia was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Tolcapone (tolcapone)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Schizophrenia | Phase 2 | Status: TERMINATED | Results posted: 2018-07-17